LABELING CHANGES TO BIO-COR EXT COLLANGEN CORNEAL— 510(k) K884364

Substantially Equivalent

Bausch & Lomb Pharmaceutical, Inc.

FDA 510(k) clearance K884364 for LABELING CHANGES TO BIO-COR EXT COLLANGEN CORNEAL, Substantially Equivalent on 1988-11-29. Applicant: Bausch & Lomb Pharmaceutical, Inc..

Clearance details

Applicant: Bausch & Lomb Pharmaceutical, Inc.
Product code: Code MOE
Advisory panel: Ophthalmic
Date received: 1988-10-20
Decision date: 1988-11-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Clearwater, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.